| Literature DB >> 35662815 |
Hye Ah Joo1, Yoon Se Lee1, Young Ho Jung1, Seung-Ho Choi1, Soon Yuhl Nam1, Sang Yoon Kim1.
Abstract
Objective: Hypopharyngeal cancer is managed by either surgical resection or radiation therapy-based treatment. In choosing the treatment modality, the patient's swallowing function should be considered to achieve optimal treatment outcomes. This study aimed to stratify the risk factors predictive of postoperative dysphagia in hypopharyngeal cancer. Study Design: Retrospective study. Setting: Tertiary referral center.Entities:
Keywords: dysphagia; hypopharyngeal cancer; percutaneous gastrostomy (PEG); posterior pharyngeal wall; tracheostomy tube
Year: 2022 PMID: 35662815 PMCID: PMC9162264 DOI: 10.3389/fsurg.2022.879830
Source DB: PubMed Journal: Front Surg ISSN: 2296-875X
Figure 1Flowchart of the enrolled patients.
Figure 2Postoperative neck computed tomography scans of each group classified by surgical resection extent. (A) Patient who underwent total laryngopharyngectomy with anterolateral thigh free flap (ALT FF) reconstruction (group 1). (B) Patient who underwent left vertical partial laryngectomy (VPL) and left pharyngectomy via lateral pharyngotomy approach with ALT FF reconstruction (group 2). (C) Patient who underwent transoral laser excision of the right posterior pharyngeal wall mass (group 3). (D) Patient who underwent right partial pharyngectomy via lateral pharyngotomy approach with ALT FF reconstruction (group 4).
Patient characteristics and univariate analysis.
| Variables | Total | Postoperative dysphagia | ||
|---|---|---|---|---|
| Yes, | No, | |||
| Demographics | ||||
| Sample size | 100 | 29 (29%) | 71 (71%) | |
| Sex | 0.857 | |||
| Male | 96 | 28 (29.2%) | 68 (70.8%) | |
| Female | 4 | 1 (25%) | 3 (75%) | |
| Age (year, mean ± SD) | 68.0 ± 8.0 | 69.1 ± 7.3 | 67.6 ± 8.3 | 0.385 |
| Neoadjuvant chemotherapy | 0.724 | |||
| Yes | 12 | 4 (33.3%) | 8 (66.7%) | |
| No | 88 | 25 (28.4%) | 63 (71.6%) | |
| Primary subsite | 0.380 | |||
| Pyriform sinus | 59 | 15 (25.4%) | 44 (74.6%) | |
| Retrocricoid region | 6 | 1 (16.7%) | 5 (83.3%) | |
| Posterior wall | 35 | 13 (37.1%) | 22 (62.9%) | |
| Histology | 0.374 | |||
| Squamous | 93 | 28 (30.1%) | 65 (69.9%) | |
| Not squamous | 7 | 1 (14.3%) | 6 (85.7%) | |
| cT stage | 0.016 | |||
| 1, 2 | 63 | 13 (20.6%) | 50 (79.4%) | |
| 3, 4a | 37 | 16 (43.2%) | 21 (56.8%) | |
| Lymph node metastasis | 0.007 | |||
| N (−) | 45 | 7 (15.6%) | 38 (84.4%) | |
| N (+) | 55 | 22 (40%) | 33 (60%) | |
| cN stage | 0.002 | |||
| 0, 1 | 62 | 11 (17.7%) | 51 (82.3%) | |
| 2, 3 | 38 | 18 (47.4%) | 20 (52.6%) | |
| Surgical approach | 0.112 | |||
| Open | 56 | 20 (35.7%) | 36 (64.3%) | |
| TLM | 36 | 6 (16.7%) | 30 (83.3%) | |
| TOVS | 2 | 0 (0%) | 2 (100%) | |
| TORS | 6 | 3 (50%) | 3 (50%) | |
| Surgical resection extent | <0.001 | |||
| Group 1 | 30 | 14 (46.7%) | 16 (53.3%) | |
| Group 2 | 12 | 5 (41.7%) | 7 (58.3%) | |
| Group 3 | 45 | 3 (6.7%) | 42 (93.3%) | |
| Group 4 | 13 | 7 (53.8%) | 6 (46.2%) | |
| Adjuvant therapy | 0.206 | |||
| None | 40 | 9 (22.5%) | 31 (77.5%) | |
| RT | 34 | 9 (26.5%) | 25 (73.5%) | |
| CCRT | 26 | 11 (42.3%) | 15 (57.7%) | |
| Follow-up (m, mean ± SD) | 33.6 ± 26.7 | 28.6 ± 26.3 | 35.6 ± 26.8 | 0.236 |
CCRT, concurrent chemoradiation therapy; SD, standard deviation; TLM, transoral laser microsurgery; TORS, transoral robotic surgery
Pearson’s Chi square test
Independent t-test
Distribution of clinical T and N classification of patients with hypopharyngeal cancer.
| N stage | Total | |||||||
|---|---|---|---|---|---|---|---|---|
| T stage | 0 | 1 | 2a | 2b | 2c | 3a | 3b | |
| 1 | 17 | 2 | 0 | 1 | 0 | 0 | 1 | 21 |
| 2 | 19 | 10 | 1 | 9 | 0 | 1 | 2 | 42 |
| 3 | 4 | 1 | 0 | 5 | 5 | 0 | 0 | 15 |
| 4a | 5 | 4 | 0 | 7 | 5 | 1 | 0 | 22 |
| Total | 45 | 17 | 1 | 22 | 10 | 2 | 3 | 100 |
Stage I, 17%; Stage II, 19%; Stage III, 17%; Stage IV, 47%.
Multivariate analysis of factors related to postoperative dysphagia.
| Variable | OR | 95% CI | ||
|---|---|---|---|---|
| Lower | Upper | |||
| cT stage | ||||
| 1, 2 | 1 | |||
| 3, 4a | 1.647 | 0.468 | 5.799 | 0.437 |
| Lymph node metastasis | ||||
| N (−) | 1 | |||
| N (+) | 1.200 | 0.254 | 5.678 | 0.818 |
| cN stage | ||||
| 0, 1 | 1 | |||
| 2, 3 | 0.307 | 0.071 | 1.334 | 0.115 |
| Surgical resection extent | ||||
| Group 1 | 1 | 0.008 | ||
| Group 2 | 1.050 | 0.241 | 4.563 | 0.949 |
| Group 3 | 12.756 | 2.387 | 68.175 | 0.003 |
| Group 4 | 0.817 | 0.189 | 3.538 | 0.787 |
CI, confidence interval; OR, odds ratio.
A binomial logistic regression model was used for the analysis.
Figure 3Kaplan–Meier survival curves. (A) Overall survival (OS) after curative surgical treatment for hypopharyngeal cancer. The median overall OS was 59.9 months, and the 5-year OS was 47.5%. (B) Kaplan-Meier survival curve comparing the patients with dysphagia and patients without dysphagia after curative surgical treatment in hypopharyngeal cancer (log-rank test; p = 0.001).